Cargando…
JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21
Cyclin D-CDK4/6 are the first cyclin-dependent kinase (CDK) complexes to be activated by mitogenic/oncogenic pathways. They have a central role in the cell multiplication decision and in its deregulation in cancer cells. We identified T172 phosphorylation of CDK4 rather than cyclin D accumulation as...
Autores principales: | Colleoni, B, Paternot, S, Pita, J M, Bisteau, X, Coulonval, K, Davis, R J, Raspé, E, Roger, P P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537611/ https://www.ncbi.nlm.nih.gov/pubmed/28368408 http://dx.doi.org/10.1038/onc.2017.7 |
Ejemplares similares
-
CDK4 T172 Phosphorylation Is Central in a CDK7-Dependent Bidirectional CDK4/CDK2 Interplay Mediated by p21 Phosphorylation at the Restriction Point
por: Bisteau, Xavier, et al.
Publicado: (2013) -
Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27
por: Coulonval, Katia, et al.
Publicado: (2021) -
Regulation of CDK4
por: Bockstaele, Laurence, et al.
Publicado: (2006) -
CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclib
por: Raspé, Eric, et al.
Publicado: (2017) -
CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas
por: Pita, Jaime M., et al.
Publicado: (2023)